Bosulif and Thinking abnormal - a phase IV clinical study of FDA data

Summary:

Thinking abnormal is reported as a side effect among people who take Bosulif (bosutinib), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Biotin, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Thinking abnormal when taking Bosulif. It is created by eHealthMe based on reports of 9,386 people who have side effects when taking Bosulif from the FDA, and is updated regularly.

What is Bosulif?

Bosulif has active ingredients of bosutinib. eHealthMe is studying from 9,401 Bosulif users. Check the latest studies of Bosulif.

What is Thinking abnormal?

Thinking abnormal is found to be associated with 1,062 drugs and 1,184 conditions by eHealthMe. Check the latest studies of Thinking abnormal.

On Jul, 24, 2026

9,386 people reported to have side effects when taking Bosulif.
Among them, 24 people (0.26%) have Thinking abnormal.

Among these 24 people:

How long have people been on Bosulif when they have Thinking abnormal? *

What is the gender of people who have Thinking abnormal when taking Bosulif? *

female: 79.17 %
male: 20.83 %

What is the age of people who have Thinking abnormal when taking Bosulif? *

What are other drugs people take besides Bosulif? *

Melatonin: 10 people, 41.67%
Biotin: 10 people, 41.67%
Lovastatin: 3 people, 12.50%
Gabapentin: 3 people, 12.50%
Latanoprost: 3 people, 12.50%
Levothyroxine Sodium: 3 people, 12.50%
Loratadine: 3 people, 12.50%
Losartan Potassium: 3 people, 12.50%
Valacyclovir Hydrochloride: 3 people, 12.50%
Metformin Hydrochloride: 3 people, 12.50%

What are other side effects people have besides Thinking abnormal? *

Fatigue (feeling of tiredness): 15 people, 62.50%
Nausea (feeling of having an urge to vomit): 13 people, 54.17%
Head Injury: 10 people, 41.67%
Back Pain: 10 people, 41.67%
Glossitis (infection of tongue with soreness): 10 people, 41.67%
Hyperkalemia (damage to or disease of the kidney): 10 people, 41.67%
Hypoaesthesia (reduced sense of touch or sensation): 10 people, 41.67%
Insomnia (sleeplessness): 10 people, 41.67%
Cerebral Disorder (brain disease): 10 people, 41.67%
Neuropathy Peripheral (surface nerve damage): 10 people, 41.67%

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 17 people, 70.83%
Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly): 10 people, 41.67%
Pain: 10 people, 41.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 10 people, 41.67%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 10 people, 41.67%
Chronic Myeloid Leukaemia (In Remission): 4 people, 16.67%
Pvt: 2 people, 8.33%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 8.33%
Essential Thrombocythaemia (chronic blood cancer): 2 people, 8.33%
Leukaemia (blood or bone marrow cancer): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Bosulif and have Thinking abnormal?

- Check whether Thinking abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bosulif:

Bosulif (9,401 reports)

Browse all side effects of Bosulif:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thinking abnormal:

Thinking abnormal (1,062 drugs)

Browse all the conditions that are associated with Thinking abnormal:

Thinking abnormal (1,184 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bosutinib (the active ingredients of Bosulif) and Bosulif (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.